Thomson Scientific: Difference between revisions

Content deleted Content added

Inline

Latest revision as of 00:41, 18 June 2023

Thomson Scientific was one of the six (later five) strategic business units of The Thomson Corporation, beginning in 2007, after being separated from Thomson Scientific & Healthcare.^[1]^[2] Following the merger of Thomson with Reuters Group to form Thomson Reuters in 2008, it became the "Scientific" business unit of the new company. In 2009, the unit came together with the Healthcare division of Thomson Reuters to form the Healthcare & Science division. The healthcare business was sold in 2012 to become Truven Health Analytics. The Science unit of Thomson Reuters provided information services for the academic, business, and R&D communities. It had headquarters in Philadelphia, London, Singapore and Tokyo with about 2,400 staff in more than 20 countries. Its products were Aureka, Delphion, Cortellis, Derwent World Patents Index (DWPI), EndNote, Horizon Global, Horizon Sourcing, IDdb, IDRAC, IP Management Services, ISI Web of Knowledge, MicroPatent PatentWeb, Techstreet Industry Standards, ThomsonPharma, GeneGo, IDDB, Thomson Regulatory Solutions, and Web of Science.^[3]

In late 2011, Thomson Reuters announced a new organizational structure, with one of its divisions being Intellectual Property & Science.^[4] This science unit of Thomson Reuters (known as IP & Science unit) was sold in 2016 to Onex and Baring Private Equity Asia for $3.5 billion. The newly independent company was named Clarivate Analytics.^[5]^[6]

References

^ "About us". www.thomson.com. Archived from the original on 30 Dec 2005. Retrieved 7 December 2021. The Thomson Corporation is organized into four global market groups: ...
^ "Thomson Announces Strategic Realignment of Operations; Company to Sell Education Businesses". www.thomson.com. Archived from the original on 11 Feb 2007. Retrieved 7 December 2021.
^ "Product Logins". www.thomsonreuters.com. Archived from the original on 16 May 2008. Retrieved 6 December 2021. The product logins page of Thomson Reuters listing their online products.
^ "Smith replaces Glocer as Thomson Reuters CEO". Reuters. 1 December 2011. Retrieved 13 July 2016.
^ Grant, Bob (2016-07-15). "Web of Science sold for more than $3 billion". The Scientist. Retrieved 2018-06-29.
^ "Acquisition of the Thomson Reuters Intellectual Property and Science business by Onex and Baring Asia completed" (Press release). Clarivate Analytics. PR Newswire. 2016-10-03. Retrieved 2018-06-29.

This article about a scientific organization is a stub. You can help Wikipedia by expanding it.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.

[1] "About us". www.thomson.com. Archived from the original on 30 Dec 2005. Retrieved 7 December 2021. The Thomson Corporation is organized into four global market groups: ...

[2] "Thomson Announces Strategic Realignment of Operations; Company to Sell Education Businesses". www.thomson.com. Archived from the original on 11 Feb 2007. Retrieved 7 December 2021.

[3] "Product Logins". www.thomsonreuters.com. Archived from the original on 16 May 2008. Retrieved 6 December 2021. The product logins page of Thomson Reuters listing their online products.

[4] "Smith replaces Glocer as Thomson Reuters CEO". Reuters. 1 December 2011. Retrieved 13 July 2016.

[5] Grant, Bob (2016-07-15). "Web of Science sold for more than $3 billion". The Scientist. Retrieved 2018-06-29.

[Analytics_2016-6] "Acquisition of the Thomson Reuters Intellectual Property and Science business by Onex and Baring Asia completed" (Press release). Clarivate Analytics. PR Newswire. 2016-10-03. Retrieved 2018-06-29.

[1]

[2]

[3]

[4]

[5]

[6]

@@ Line 1: / Line 1: @@
+{{Short description|Strategic business unit}}
-{{Articleissues|article=y|newsrelease=January 2008|primarysources=February 2008}}
+'''Thomson Scientific''' was one of the six (later five) [[strategic business unit]]s of [[The Thomson Corporation]], beginning in 2007, after being separated from Thomson Scientific & Healthcare.<ref>{{cite web|url=http://www.thomson.com/corp/about/ab_home.jsp |title=About us |website=www.thomson.com |access-date=7 December 2021 |url-status=dead |archive-url=https://web.archive.org/web/20051230071516/http://www.thomson.com/corp/about/ab_home.jsp |archive-date=30 Dec 2005 |quote=The Thomson Corporation is organized into four global market groups: ...}}</ref><ref>{{cite web|url=http://www.thomson.com/content/pr/corp/corp_news/139161 |title=Thomson Announces Strategic Realignment of Operations; Company to Sell Education Businesses |website=www.thomson.com |access-date=7 December 2021 |url-status=dead |archive-url=https://web.archive.org/web/20070211063911/http://www.thomson.com/content/pr/corp/corp_news/139161 |archive-date=11 Feb 2007}}</ref> Following the merger of Thomson with [[Reuters Group]] to form [[Thomson Reuters]] in 2008, it became the "Scientific" business unit of the new company. In 2009, the unit came together with the Healthcare division of Thomson Reuters to form the Healthcare & Science division. The healthcare business was sold in 2012 to become [[Truven Health Analytics]]. The Science unit of Thomson Reuters provided information services for the academic, business, and R&D communities. It had headquarters in [[Philadelphia]], London, Singapore and Tokyo with about 2,400 staff in more than 20 countries. Its products were Aureka, Delphion, Cortellis, [[Derwent World Patents Index]] (DWPI), [[EndNote]], Horizon Global, Horizon Sourcing, IDdb, IDRAC, IP Management Services, [[ISI Web of Knowledge]], [[MicroPatent]] PatentWeb, Techstreet Industry Standards, ThomsonPharma, GeneGo, IDDB, Thomson Regulatory Solutions, and [[Web of Science]].<ref>{{cite web
-{{nofootnotes|date=February 2008}}
+ |url=http://www.thomsonreuters.com/content/footer/product_logins |title=Product Logins |website=www.thomsonreuters.com |access-date=6 December 2021 |url-status=dead |archive-url=https://web.archive.org/web/20080516030443/http://www.thomsonreuters.com/content/footer/product_logins |archive-date=16 May 2008}} The product logins page of Thomson Reuters listing their online products.</ref>
+In late 2011, Thomson Reuters announced a new organizational structure, with one of its divisions being Intellectual Property & Science.<ref>{{cite web |url= https://www.reuters.com/article/us-thomsonreuters-glocer-idUSTRE7B02WB20111202 |title=Smith replaces Glocer as Thomson Reuters CEO |first= |last= |date=1 December 2011 |publisher=Reuters |accessdate=13 July 2016}}</ref> This science unit of Thomson Reuters (known as IP & Science unit) was sold in 2016 to [[Onex Corporation|Onex]] and [[Baring Private Equity Asia]] for $3.5 billion. The newly independent company was named [[Clarivate Analytics]].<ref>{{Cite web |first=Bob |last=Grant |url=https://www.the-scientist.com/?articles.view/articleNo/46558/title/Web-of-Science-Sold-for-More-Than--3-Billion/ |title=Web of Science sold for more than $3 billion|website=The Scientist |date=2016-07-15 |access-date=2018-06-29}}</ref><ref name="Analytics 2016">{{cite press release |author=<!--Staff writer(s); no by-line.--> | publisher=Clarivate Analytics | title=Acquisition of the Thomson Reuters Intellectual Property and Science business by Onex and Baring Asia completed | agency=PR Newswire | date=2016-10-03 | url=https://www.prnewswire.com/news-releases/acquisition-of-the-thomson-reuters-intellectual-property-and-science-business-by-onex-and-baring-asia-completed-300337402.html | access-date=2018-06-29}}</ref>
-'''Thomson Scientific''' was one of the five operating divisions of [[The Thomson Corporation]] until 2008. Following the merger of Thomson with [[Reuters]] to form [[Thomson Reuters]] in 2008, it became the ''Scientific'' business unit of the new company. In 2009, the Scientific business came together with the Healthcare business to form the Healthcare & Science business of Thomson Reuters. The Science unit provides information-based solutions for the academic, business and R&D communities.
+==See also==
-The Science business of Thomson Reuters has headquarters in [[Philadelphia]], London, Singapore and Tokyo with about 2,400 staff in more than 20 countries.
+*[[Institute for Scientific Information]]
+==References==
-The Science business of Thomson Reuters provides integrated information solutions with brands like: [[Aureka]], Delphion, [[Derwent World Patents Index]] (DWPI), [[EndNote]], Horizon Global, Horizon Sourcing, IDdb, IDRAC, IP Management Services, [[ISI Web of Knowledge]], Liquent Insight Suite, [[MicroPatent]] PatentWeb, Techstreet Industry Standards, Thomson-Pharma, IDDB, Thomson Regulatory Solutions, and [[Web of Science]].
+{{Reflist}}
+[[Category:Thomson Reuters]]
+[[Category:Clarivate]]
-==TPharma==
-The old legacies have been progressively integrated and enriched.
-TPharma represents that basic platform for the Life Science area, specialized with Pharma/Chem area.
-It has a Portal with the widest search mechanism. The associated Federate search is the must accurate and reliable search mechanism offered by Thomson Reuters.
-It covers older applications (IDDB, ISI, IDdb, Delphion, Web of Science) and it supports almost all the specialistic format in the industry. It has a strong leverage on Financial information coming from Reuters and Thomson Financial.
-The current release is 9.1.1.
-==See also==
-*[[Institute for Scientific Information]]
-==External links==
-*[http://www.thomsonreuters.com/business_units/scientific/ Website of the Scientific unit of Thomson Reuters]
-*[https://www.thomson-pharma.com/ TPharma login page]
-*[https://login.thomson-pharma.com/tp/media/pdf/thomson-pharma-qrc-en.pdf Basic information about TPharma]
-*[http://www.highbeam.com/doc/1G1-146090720.html R&D specialist aquired to bolster Thomson Pharma ]
-*[http://www.shore.com/commentary/weblogs/2005/07/organic-chemistry-can-thomson-pharma.html Organic Chemistry: Can Thomson Pharma Provide Organic Growth?]
-[[Category:Thomson Reuters Life Science family]]
-{{science-stub}}
+{{science-org-stub}}
 {{med-company-stub}}